Portfolio data

Browse all portfolio data news

Search

Latest portfolio data news

Show news from

all companies
all Cell therapy companies
all Gene Therapy companies
all Biologics companies
Anaveon
all Small molecule companies

10.11.22

Anaveon presents updated data from the Phase I/II study of ANV419 during the SITC Annual Meeting

Operating News
Biologics
Anaveon

12.09.22

Anaveon presents updated data from the Phase I/II study of ANV419 during the ESMO Congress 2022

Operating News
Biologics
Anaveon

11.04.22

Anaveon presents compelling data from the Phase I/II study of ANV419 during the AACR Annual Meeting 2022

Biologics
Anaveon

Sign-up for company news alerts

Get the latest RNS, company news, share price information and results from Syncona

RNS alerts
Company alerts

Syncona Investment Management Limited
2nd Floor
8 Bloomsbury Street
London
WC1B 3SR

contact@synconaltd.com

About us
Our people
Portfolio
Sustainability
News and insights
Investors
Contact

Accessibility
Privacy & cookies
Employee privacy notice
Third party privacy notice
Regulatory publications
Modern slavery statement

Syncona Limited is registered in Guernsey no. 55514, registered office Frances House, PO Box 273, Sir William Place, St. Peter Port, Guernsey, GY1 3RD.
Syncona Investment Management Limited is registered in England no. 10497864, 8 Bloomsbury Street, London WC1B 3SR and is authorised and regulated by the FCA. Syncona Limited is managed by Syncona Investment Management Limited.

threethirty.studio

About us
Our people
Portfolio
Sustainability
News and insights
Investors
Contact

GBX 112.97

Change: -0.43 (-0.38%)

Search